- Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupYousif Matloub
Division of Hematology Oncology, Rainbow Babies and Children s Hospital, Case Western Reserve University, Cleveland, OH 44106, USA
Blood 118:243-51. 2011..71, P = .12). No advantage was found for a second DI; however, replacement of PO MTX, PO mercaptopurine, vincristine, and dexamethasone during IM with vincristine and escalating IV MTX improved EFS...
- Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trialLinda C Stork
Division of Hematology Oncology, Doernbecher Children s Hospital Oregon Health and Science University, Portland, OR 97239, USA
Blood 115:2740-8. 2010..65, P = .002). The toxicities of TG preclude its protracted use as given in this study. This study is registered at http://clinicaltrials.gov as NCT00002744...
- Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment StrategiesYousif Matloub
Rainbow Babies and Children s Hospital, Division of Hematology Oncology, Case Western Reserve University, Cleveland, Ohio
Pediatr Blood Cancer 63:255-61. 2016..The Pediatric Oncology Group (POG) treated all the patients with T-ALL on separate, generally more intensive protocols than those used to treat the patients with B-ALL...